Loading Events

This event has passed.

WEBINAR: Turning a Great Idea into a Great Business with IP: From Therapeutics to Digital Health

Wednesday 18 October 2023 @ 10:00 am - 11:00 am BST

Join attorneys Peter Mumford and Daniel Hudson from Potter Clarkson LLP, for a practical discussion on the real-world experiences of two early-stage MedTech companies. They will present anonymized case studies that shed light on the complexities of managing intellectual property (IP) for young MedTech businesses. Using these real-life examples, they will highlight the specific IP issues such companies encounter as they work towards innovation in healthcare.

Details on the case studies:

– Case study one will focus on a MedTech start-up in the therapeutics space, where Peter and Daniel will explore the challenges they faced in protecting their IP while striving to bring to market a product that will make a difference in patient care.

– Case study two revolves around a MedTech company developing a novel medical device with a strong digital health component. Peter and Daniel will examine the unique IP considerations that arise in this context.

Throughout these cases, they will share practical strategies that have assisted their clients in their journey from idea conception to establishing themselves in the MedTech sector.

By the end of the webinar you will walk away with actionable insights that can benefit entrepreneurs, investors, and industry enthusiasts as they navigate the IP landscape in healthcare innovation.

Join us for an informative session where we delve into the challenges and solutions in the early stages of MedTech innovation. Gain a clearer understanding of how intellectual property plays a crucial role in the growth of visionary companies and the advancement of healthcare.

Speaker Profiles 

Daniel Hudson, Partner – Patent Attorney, Potter Clarkson
Daniel is an experienced UK and European patent attorney and a partner in the firm’s electronics and computing group.
Daniel drafts and prosecutes UK and European patent applications in a wide range of technologies. He also works with foreign patent attorneys to manage the international prosecution of families of patent applications on behalf of our clients. He particularly enjoys the challenges involved with prosecuting related families of patent applications to obtain comprehensive protection for his client’s inventions in view of their commercial objectives. In particular, he has extensive experience prosecuting complex patent families in the fields of fuel cell systems and navigation technology, including primary responsibility for the drafting or prosecution of several hundred patent applications.
Daniel is a patent attorney litigator with a right to conduct litigation and a right of audience in the Intellectual Property Enterprise Court (IPEC), and a right to conduct litigation in the High Court. He works closely with the firm’s litigation team to enforce his clients’ IP rights.
Daniel also prepares oppositions and third-party submissions on behalf of clients who wish to oppose the grant of a third party’s patent at the European Patent Office (EPO). Such action may clear the way for our clients to operate in a particular area, or otherwise improve their commercial position. Most of his experience in this area is in the medical technology or consumer product space.

Peter Mumford, Senior Associate – Patent Attorney, Potter Clarkson
Peter is a patent attorney specialising in the pharmaceutical and chemical fields; his main areas of interest include small molecule pharmaceuticals, biocides, medical treatments, and process chemistry.
He has a wide range of experience in patent drafting, national patent prosecution, due diligence, portfolio management, and oppositions and appeals before the European Patent Office.
Peter read Chemistry at the University of Warwick and obtained a PhD in Synthetic Organic Chemistry from the same institution.  After gaining experience as a postdoctoral research associate at the University of Nottingham, Peter honed his expertise in the pharmaceutical industry by spending five years as a medicinal chemist at Sygnature Discovery.  He joined Potter Clarkson in October 2015.

 

Terms and Conditions for all events

To read through the terms and conditions of our events, please click here.

Code of conduct for all events

To read through the code of conduct expected by all event attendees please read Code of Conduct – Medilink Midlands Events.